PPA
PRVB

Parametric Portfolio Associates’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Parametric Portfolio Associates’s Portfolio PRVB Stock Details PRVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$492K Sell
67,219
-93,183
-58% -$557K ﹤0.01% 3103
2021
Q4 		$901K Sell
160,402
-19,976
-11% -$127K ﹤0.01% 2824
2021
Q3 		$1.15M Sell
180,378
-41,096
-19% -$264K ﹤0.01% 2738
2021
Q2 		$1.87M Buy
+221,474
New +$1.79M ﹤0.01% 2479

Other funds holding PRVB

SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

Parametric Portfolio Associates's PRVB Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Provention Bio, Inc. Common Stock (PRVB) stake by 58% in Q1 2022, selling an estimated $557K and leaving 67,219 shares worth $492K. The position accounts for ﹤0.01% of the portfolio, ranked #3103.

Parametric Portfolio Associates first reported a position in PRVB in Q2 2021 and has held it in 4 quarters since. The position peaked at $1.87M in Q2 2021. 113 funds tracked by Wall St. Rank hold PRVB as of Q1 2022.

  • Parametric Portfolio Associates held 67,219 shares of Provention Bio, Inc. Common Stock worth $492K as of Q1 2022.
  • Parametric Portfolio Associates sold 93,183 Provention Bio, Inc. Common Stock shares in Q1 2022, an estimated $557K.
  • Provention Bio, Inc. Common Stock made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3103 holding.
  • Parametric Portfolio Associates first reported a position in Provention Bio, Inc. Common Stock in Q2 2021 and has held it in 4 quarters since.
  • Parametric Portfolio Associates's Provention Bio, Inc. Common Stock position peaked at $1.87M in Q2 2021.
  • 113 funds tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.